Recent data have shown that a selective α7 nAChR agonist completely restored cognition in an aged triple transgenic mice model of AD (3x Tg-AD) with severe AD-like pathology [58] suggesting that stimulation of α7 nAChR may oppose cognitive deficits induced by both tau and β-amyloid pathologies. Here, MAPT is linked to Alzheimer disease.